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Functional roles of amino acids have increasingly become the focus of research. This paper summarizes amino acids that
inﬂuence cardiovascular system via the brain of conscious rats. This paper ﬁrstly describes why amino acids are selected and
outlines how the brain regulates blood pressure and regional blood ﬂow. This section includes a concise history of amino acid
neurotransmitters in cardiovascular research and summarizes brain areas where chemical stimulations produce blood pressure
changes mainly in anesthetized animals. This is followed by comments about ﬁndings regarding several newly examined amino
acids with intracisternal stimulation in conscious rats that produce changes in blood pressure. The same pressor or depressor
response to central amino acid stimulations can be produced by distinct mechanisms at central and peripheral levels, which will be
brieﬂy explained. Thereafter, cardiovascular actions of some of amino acids at the mechanism level will be discussed based upon
ﬁndings of pharmacological and regional blood ﬂow measurements. Several examined amino acids in addition to the established
neurotransmitter amino acids appear to diﬀerentially activate brain structures to produce changes in blood pressure and regional
blood ﬂows. They may have physiological roles in the healthy brain, but pathological roles in the brain with cerebral vascular
diseases such as stroke where the blood-brain barrier is broken.
1.Introduction
When the rat spontaneously performs an action such as
grooming [1] or walking [2], changes in regional blood ﬂows
for head and legs are produced. The brain appropriately
regulates blood supply to organs needed for planning of
each behavior. For matching cardiovascular demand to each
behavior, various kinds of potential neurotransmitters and
neuromodulators should work in neuronal networks of the
brain relating to the cardiovascular system and behavioral
planning. A list of neurotransmitters includes the amino
acids glutamate and GABA (gamma-amino-butyric acid)
which are well established as endogenously produced exci-
tatory and inhibitory agonists, respectively [3], and appear
to play a pivotal role in the central nervous system relating
to cardiovascular regulation [4–7]. However, it has been
expanding to range the kind and the number of mediators
between brain cells from classic neurotransmitter biogenic
amines to gaseous neurotransmitters [8] and to gliotrans-
mitters [9]. With respect to amino acids, the concentration
of most amino acids in the cerebrospinal ﬂuid is lower than
those in the blood [10]. The blood-brain barrier eﬀectively
protects the brain from inﬂuence of ﬂuctuating concentra-
tionsofplasmaaminoacids[11].Whyaretheconcentrations
of amino acids kept lower in the cerebrospinal ﬂuid? Amino
acids other than the established neurotransmitter amino
acids may have some functional roles in the brain as is the
case with the established ones. The brain contains many
nuclei regulating blood pressure and regional blood ﬂow
via several pathways [4, 12]. I have hypothesized that some
amino acids inﬂuence the cardiovascular system through
the brain. I have, therefore, begun examining the responses
of the cardiovascular system to brain stimulations with
amino acids [13, 14]. The anesthesia works at brain level
to cause immobility and unconsciousness in animals mainly
via GABAa receptors [15], resulting in modiﬁed states of
the neural networks diﬀerent from the un-anesthetized state
[16]. Therefore, the un-anesthetized freely moving rat has
been used in the examinations of brain stimulation with
an intracisternal injection of amino acid solution. I will2 Journal of Amino Acids
mention ﬁndings on several amino acids that modulate the
cardiovascularsysteminthispaper,afterconciselydescribing
the basic knowledge of central cardiovascular regulation.
See references for details: hemodynamics [17, 18], central
cardiovascular regulation [12, 19–21], or recent knowledge
on amino acids including various functions [22]. In the
following sections, I will summarize ﬁndings on several
amino acids in addition to the established amino acid
neurotransmitters(GABA,glycine,andglutamate)thatshow
functional roles in modifying the cardiovascular system.
Understanding the mechanisms of how the brain operates is
stillagreatchallenge.Iwouldliketosuggestthataminoacids
other than the established amino acid neurotransmitters
and/or neuromodulators may have an important role in how
the brain functions.
2.Why AreAmino Acids the Focus?
My ﬁrst concern was roles of the blood-brain barrier. One of
therolesistohelptomaintainlowerconcentrationsofamino
acids in the cerebrospinal ﬂuid than in the plasma [10].
Concentrations of L-proline and L-cystine (dimer of L-
cysteine) in the cerebrospinal ﬂuid are extremely low [10].
Why has the brain developed to maintain lower values of
such amino acids in the cerebrospinal ﬂuid? The brain tissue
surrounding the route of the cerebrospinal ﬂuid may be
aﬀected by higher concentrations of L-proline or L-cysteine.
Central response to an amino acid might give a clue to
decipher the neural wiring relating to proper blood ﬂow shift
in animal behaviors. This is the reason I have focused on the
roleofaminoacidsinthebrainforcardiovascularregulation.
Our whole body uses only 20 amino acids to synthesize
proteins and peptides, among more than 300 natural amino
acids known at present [22]. One of those proteinogenic
amino acids, L-glutamate,hasbeenrecognized asanendoge-
nous neurotransmitter for excitatory amino acid receptors at
synapses of the central nervous system for several decades
[23–25]. Other established historical inhibitory amino acid
agonists are GABA, and glycine, which is also one of
20 brick amino acids for proteins [25, 26]. Interestingly,
evolutionary process utilizes the ubiquitous nutrient amino
acids glutamate and glycine in the brain and spinal cord
to signal and communicate between neurons with elaborate
mechanisms. Extremely high tissue contents of L-glutamate,
GABA, and glycine in the central nervous system [10, 27]
would suggest a highly evolved control system that uses these
amino acids for the basic common wiring plan to maintain
homeostasis throughout the body. Research on the eﬀects
of amino acids in the central nervous system began in 1952
with a report from Hayashi on the central convulsive action
of glutamate [28, 29]. A possible role of neurotransmitters
for amino acids was discussed according to neurotransmitter
criteriain1974byCurtisandJohnston[30].Theymentioned
possible neurotransmitter roles of other amino acids in
addition to the later established neurotransmitter amino
acids.
With respect to cardiovascular control, GABA, glycine,
and glutamate have been known to have an eﬀect on blood
pressure since 1954 [31–35]. Takahashi’s group ﬁrst reported
a depressor eﬀect of intravenously injected GABA in 1955
[31] and later identiﬁed acting sites of GABA as the central
origin using various approaches such as ganglionic blocking,
intracisternal injection, and direct stimulation with topical
application of GABA solution on the dorsal medulla of the
anesthetized animal [32]. Intracisternal injection of glycine,
GABA, taurine, and L-α-alanine into ether-anesthetized rats
produced a central depressor action [33]. As for a pressor
response, intravenous injection of glutamate was reported
to raise blood pressure of the dog by Itoga in 1954 [34]
and of rabbits later by Takahashi’s group [31]. Itoga had
already suggested the vasomotor centre of the medulla as the
active site for the pressor response to intravenously injected
glutamate[34].Intracisternalinjectionofglutamatewaslater
examined and found to produce a strong pressor response
in dogs [35]. In studies of central cardiovascular regulation,
concern of most researchers appears to have focused on
excitant amino acids mainly as tools of chemical stimulation
for electrical stimulation to evoke excitation of only neurons
butnotaxonsrelatedtobloodpressureregulation.Forexam-
ple, homocysteic acid [29] has been repeatedly selected to
stimulate neurons as a stimulant tool for targeting excitatory
receptors [36–38]. Several groups nevertheless have contin-
ued to investigate the role of chemical mediators in central
cardiovascular regulation [5–7]. In future, information on
which neurons related to cardiovascular regulation have
which neurotransmitters identiﬁed with classical criteria:
storage, release, and inactivation, might become available
[8].
3. Outlineof How the BrainRegulates Blood
PressureandRegionalBloodFlow
Blood pressure (speciﬁed for arterial blood pressure here) is
determined by cardiac output and total peripheral resistance
(Figure 1). The heart works spontaneously and propels the
blood into the aorta depending on blood volume returned
from the vena cava. The brain modiﬁes the cardiac work
with cardiac parasympathetic and sympathetic neurons,
adrenaline released from the adrenal gland via sympathetic
activation, and an increase in venous return with increased
sympathetic activity to the capacitance venous vessels.
Anothervariableofperipheralbloodﬂowresistancesconsists
of a lot of acting sites, arterioles all over the body, which
are located just before the vascular (capillary) bed of each
organ (Figure 2). The brain can modify the size of arterioles
with vascular sympathetic neurons and release of several
vasoactive factors into the blood stream as mentioned below
indetail.Forproperdeliveryofthebloodintothedemanding
organ, regulation of the arterioles could be essential. Vaso-
motor sympathetic neurons are tonic at rest but regulated
by increasing or decreasing activities (Figure 3), resulting in
optimal blood ﬂow shift among diﬀerent vascular beds for
demanding organs, in theory.
3.1. Brain Has at Least Four Possible Peripheral Pathways for
Inﬂuencing Arterioles. Stimulation of central nervous systemJournal of Amino Acids 3
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Figure 1: Blood pressure is produced by cardiac output and total
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Figure 2: Vascular sympathetic nerves innervate mainly arterioles
located just before the vascular bed in each organ. The heart is
innervated by both parasympathetic and sympathetic neurons.
inﬂuences arterioles and/or blood pressure through at least
four ways (Figure 4)[ 39]: one is the vasomotor sympathetic
neurons in diﬀerent vascular beds (Figures 2 and 4 circle 1),
second is renal sympathetic neurons (Figure 4 circle 2) that
release the enzyme renin from the renin-secreting granular
cells in the aﬀerent arteriole to ﬁnally produce a potent
vasoactive peptide, angiotensin II, in the blood via the renin-
angiotensin system [40, 41], third is adrenal sympathetic
neurons (Figure 4 circle 3) that release adrenaline into
the blood [42], and ﬁnally the hypothalamus-pituitary
system that releases the vasoactive or antidiuretic peptide,
vasopressin, in the blood (Figure 4 circle 4) [19]. Central
excitatory stimulation of those pathways induces a simple
pressor response through vasoconstriction by noradrenaline,
angiotensin II, and vasopressin and/or increase in cardiac
output with adrenaline, but inhibitory stimulation produces
a depressor response where the corresponding tonic pathway
at rest is deactivated. Because total vascular tone is mainly
maintainedbyvasomotorsympatheticneuronsintheanimal
withnormalbloodpressure,responsesofregionalbloodﬂow
resistances to inhibitory stimulation would aﬀect vascular
Vascular 
sympathetic 
nervous activity
Basal tone 
At rest
Spinal cord 
Sympathetic 
ganglion
Decreased activity Increased activity
Figure 3: Tonic activities of vascular sympathetic nerves at various
levels allow for regulation of ﬂow rate. Basal tone at rest increased
by sympathetic nervous activation produces vasoconstriction and
a decrease in blood ﬂow rate (an increase in resistance). When
basal tone is inactivated, vasodilatation, an increase in ﬂow rate (a
decrease in resistance), is produced.
beds which are tonic at rest and responsible for maintaining
the normal blood pressure. In the same way, genetically
or experimentally produced hypertensive animals could be
examined with blockade of the above-mentioned four possi-
ble peripheral pathways to elucidate the cause of prolonged
hypertensive states.
3.2. Brain Nuclei Where Chemical Stimulations Produce
ChangesinBloodPressure. Chemicalstimulationofthebrain
has been used to produce changes in blood pressure, because
they are expected to stimulate only the cell body of the
neuron [44]. As stimulants, ionotropic excitatory amino acid
receptor agonists, L-glutamate, DL-homocysteic acid, and
kainic acid, have been chosen for most cases, but other
chemicals such as serotonin, acetylcholine, GABA, glycine,
angiotensin II, endothelin, and receptor agonists and antag-
onists have also been tested.
There are several well-examined neuronal groups which
change blood pressure at medulla level when chemically
stimulated (Figure 5); rostral ventrolateral medulla (RVLM)
[16, 45–49], caudal ventrolateral medulla (CVLM) [47, 50–
56], and nucleus tractus solitarii (NTS) [57–64]. Neural
pathways of a reﬂex which detects changes in blood pressure
and returns it to the original level via mainly sympathetic
neurons(calledthebaroreceptorreﬂex)includeNTS,RVLM,
and CVLM. Baroreceptor aﬀerent neurons of vagal and
glossopharyngeal nerves terminate second-order neurons
in the NTS [65–67] that send information to GABAergic
interneurons in the CVLM [68]. When baroreceptors in
the aortic arch and carotid sinus detect an increase in
blood pressure, excited GABAergic neurons in the CVLM
inhibit presympathetic neurons in the RVLM, leading to a4 Journal of Amino Acids
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Figure 4: Potential pathways between the central nervous system
(CNS) and the cardiovascular system. The CNS regulates the
cardiovascular system using various peripheral routs. Arterioles
can be regulated by sympathetic neurons and humoral factors
of angiotensin II (A II), vasopressin (VP), and adrenaline (Adr),
resulting in changes in total peripheral resistance. The heart is
regulated by both of parasympathetic and sympathetic neurons
and Adr. Capacitance venous vessels are regulated by sympathetic
neurons and modify returning blood volume to the heart and
cardiac output as predicted by Starling’s law. Renal sympathetic
neurons can release the enzyme renin from the juxtaglomerular
apparatus into the blood via β1 adrenoceptors. The renin produces
A II via the renin-angiotensin system. The hypothalamus-pituitary
system in the forebrain releases VP into the stream. A II and VP
constrict arterioles markedly. Adrenal sympathetic neurons release
Adr into the blood. The central nervous system monitors arterial
blood pressure with visceral aﬀerents terminated in the big arteries.
Ach: acetylcholine, Nor: noradrenaline. circles 1–4; see text.
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Figure 5: Potential brain nuclei of which neurons respond to
intracisternal injection of amino acid solution, in the sagittal view
of the rat brain. SON, the supraoptic nucleus of the hypothalamus;
NTS, the nucleus tractus solitarii; RVLM, rostral ventrolateral
medulla; CVLM, caudal ventrolateral medulla; CPA, caudal pressor
area. Gray area indicates the ventricular system from the third
ventricle to the central canal in the spinal cord.
decrease in sympathetic activity and resulting in restoration
of original blood pressure [21]. RVLM is believed to contain
the most essential neuronal group to maintain the resting
and tonic vasomotor sympathetic activity, since lesion or
inhibition of RVLM produces severe hypotension equivalent
to a spinal transection [50, 69] and blockade of many
cardiovascular-related reﬂexes [12].
Other parts of the brain that produce changes in blood
pressure with chemical stimulation include caudal pressor
area (CPA) (Figure 5)[ 70], area postrema [71], rostral
ventromedial medulla [72–74], caudal raphe nuclei [75–79],
nucleus ambiguous [80] ,c e r e b e l l a rs u b l o b u l eI X( l a t e r a la n d
medial uvula) [81–85], and the fastigial nucleus [4, 44,
86–89] at the medulla and cerebellum. The others are
A5 noradrenergic cell group [90–92], locus coeruleus (A6
group) [93, 94], parabrachial area [95–100] in the pons,
ventral tegmental area [101–103] and periaqueductal gray
matter [104–106] at the midbrain level, and lateral and
posterior hypothalamic regions [105, 107–110], amygdala
[111, 112], septal nuclei [113], and insular cortex [114, 115]
at the forebrain level. Vasopressin-containing neurons in
the supraoptic nucleus and paraventricular nucleus of the
hypothalamus are also responsible for the pressor response
to chemical stimulation via vasopressin release even in awake
rats [116, 117].
Neural networks made from the above-mentioned neu-
ronal groups and yet unknown ones could regulate blood
pressure and regional blood ﬂow to the vascular bed,
corresponding to various needs of the body. Synapses in
the neuronal networks should have a lot of combinations of
endogenous agonists and receptors like those in autonomic
nerves [118], sympathetic preganglionic neurons [119], and
medullary presympathetic neurons [7]. A lot of work has
been devoted to ﬁnding the mechanisms for the appropriate
responses to complicated body needs with expanding lists of
neurotransmitters and their receptors related to cardiovas-
cular regulation [4, 6, 7, 12, 119]. However, the details of
in vivo body function at the synaptic level remain poorly
understood.
4. PotentialDiffusedParts of the Brain with
IntracisternalApproach
Intracisternal injection of chemical solution has several
merits for surveying central eﬀects of a lot of amino acids.
First, limited areas of the brain around the cisterna magna
could be stimulated (Figure 5). The cerebrospinal ﬂuid ﬂows
from the lateral ventricles to the cisterna magna through
the third ventricle, the aqueduct, and the fourth ventricle,
with weak positive pressure [10]. Potential diﬀused regions
with intracisternal injections in the freely moving rat are
the ventral medulla surface, excluding part of the dorsal
brainstem, and the surface areas around the ﬂow route of
the cerebrospinal ﬂuid [120]. The ﬂow route includes the
RVLM, CVLM, and CPA located in the ventral surface of
the medulla and the NTS located in the dorsal surface of the
medulla.TheNTSneuronsreceiveaﬀerentinformationfrom
the body [121] and contribute to keep blood pressure stableJournal of Amino Acids 5
via mainly the CVLM then to the RVLM in the baroreceptor
reﬂex [12, 21]. The CPA neurons appear to be included for
maintenance of blood pressure but via the RVLM and/or
CVLM [21]. Therefore, the RVLM and CVLM would have
the greatest inﬂuence over changes in blood pressure with
intracisternal stimulation of amino acids, as the ﬁnal stations
of the possible network. I have established the intracisternal
injection method using polyethylene tubing that produces a
minimal lesion of the brain, diﬀerently from a stainless steel
tube. It was originally developed to take cerebrospinal ﬂuid
from freely moving rats [122, 123]. For injection of amino
acid solution, the tip was inversely oriented from a caudal
side to a rostral side. With respect to acting sites, my recent
studies with c-Fos expression [124] and another study using
a radioisotope [125] suggest the supraoptic vasopressin-
containing nuclei situated in the ventral surface area of the
brain in addition to RVLM and CVLM.
5. Amino Acidswith a Pressor Action
In the ﬁrst experiment [13], while blood pressure and heart
rate were observed, the following amino acid solutions
were intracisternally injected in the freely moving rat: L-
glutamic acid (59nmol in 10μL artiﬁcial cerebrospinal ﬂuid,
5.9mM), taurine (5μmol), L-proline (10μmol), L-α-alanine
(10μmol), GABA (10μmol), L-aspartic acid (0.3μmol),
L-valine (7.6μmol), L-serine (10μmol), L-methionine
(1μmol), L-isoleucine (3μmol), L-leucine (1μmol), L-
tyrosine (25nmol), L-histidine (5μmol), L-lysine (10μmol),
L-arginine (10μmol), L-tryptophan (56nmol), L-asparagine
(1.4μmol), L-glutamine (2μmol), glycine (10μmol), L-
phenylalanine (0.18μmol), and L-cysteine (10μmol). Each
dose depended on the solubility but was below 10μmol in
10μL. In the later detailed experiments, L-glutamic acid
monosodium salt (0.2M) was used for improvement of
solubility [126], the concentration of L-cysteine was lowered
to 0.2M from 1M due to its strong spasm causing eﬀect
[126], and the pH of basic L-arginine solution was adjusted
to 7.4 [127]. To examine the stereoselectivity of the pressor
response to L-arginine and L-proline, D-arginine [128]a n d
D-proline [129] were injected in other experiments.
Intracisternal injections of the following amino acids
produced pressor responses in the freely moving rat: L-
proline, L-arginine, D-arginine, L-cysteine, L-glutamate, L-
aspartic acid, and L-asparagine [13, 126–129]. The pressor
responses were dose dependent, became maximal between
1min and 10min after injections, and returned to normal
within 60min at longest for all except D-arginine. An
increase in heart rate was marked between 1 and 5min
afterinjection of L-cysteine,and a bradycardiacresponse was
obtained 5min after injection of L-proline [13].
An examination of stereoselectivity for the L-arginine
response revealed unexpectedly a pressor response to D-
arginine injected into the cisterna magna [128]. Because of
a possible role of the enzymatic substrate L-arginine for
nitric oxide [130], no response to D-arginine stimulation
was predicted. Other possibilities as substrates are for
kyotorphin(L-tyrosyl-L-arginine)[131]andagmatine[132].
The pressor responses common to both L-arginine and D-
arginine apparently denied the possibility as a substrate
of L-arginine for the converted diﬀerent active principles,
becauseofstrictstereospeciﬁcityoftheenzymes.However,as
mentioned below, each mechanism for the pressor response
was distinct. Active principles of L-arginine and D-arginine
for their cardiovascular responses remain puzzling.
A weak depressor response to D-proline was obtained
[129]. Therefore, it is suggested that the neurotransmitter
candidate L-proline [133] itself acts on some receptors in the
neuronal network relating to cardiovascular regulation.
6. Amino Acids witha Depressor Action
Intracisternal injection of the following amino acids pro-
duced depressor responses in the freely moving rat: L-
serine, L-sarcosine (N-methyl-glycine), L-α-alanine, L-β-
alanine, taurine, GABA, and glycine [14, 43, 134, 135]. The
concentration was 1M for all except taurine which was
0.5M.
The depressor and bradycardiac responses were at max
b e t w e e n5 m i na n d3 0 m i na f t e ri n j e c t i o n s ,a n db l o o d
pressure returned to the original level 60min or later. The
depressorresponsetoL-serinewasoccasionallyaccompanied
with transient pressor period between 5 and 10min [14,
134], diﬀerently from other depressor amino acids. The
mechanismofL-serinetoinducetwo-phasechangesinblood
pressure could be diﬀerent from others. Of these depressor
amino acids, L-serine, L-α-alanine, and L-β-alanine have
been introduced as electrophysiologically depressant amino
acids related structurally to GABA, glycine, and taurine by
Curtis and Johnston [30]. Then, L-β-alanine is suggested to
be a neurotransmitter at present [136].
7. Regional Blood Flow Changes with Several
Amino Acids of the Pressor Action
Regionalbloodﬂowmeasurementinthreearteries(Figure 6)
wasperformedforL-proline,L-arginine,andD-arginine.In-
formation on changes in regional blood ﬂow will give a clue
to decipher how an amino acid modiﬁes regional peripheral
resistance and changes blood pressure.
Beforeseeingthehemodynamicdata,explanationofﬂow
measurement and relationship among regional blood ﬂow,
regional blood ﬂow resistance, and blood pressure would
be needed. An electromagnetic ﬂow probe set around the
artery monitors the ﬂow volume rate (not velocity) in the
freely moving rat [137]( Figure 6). The blood ﬂow rate
(volume/min/100gweight)measuredinanarteryjustbefore
the vascular bed of an organ reﬂects the net changes in sizes
of arterioles within the organ. Namely, stronger arteriolar
dilatation produces more arterial blood ﬂow, but stronger
vasoconstriction produces less ﬂow. At rest, the size of
arteriole is mainly determined by the basal tone of vascular
sympathetic neurons (Figure 3). When the vascular sympa-
thetic discharge is increased, the resultant vasoconstriction
reduces ﬂow to the corresponding artery. When arterioles in
a particular vascular bed are not under the control of6 Journal of Amino Acids
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Figure 6: Regional blood ﬂow measured in three arteries after
intracisternal injection of L-proline, L-arginine, or D-arginine. SM,
superior mesenteric artery; R, renal artery; HQ, hindquarter or the
terminal aorta. Each experiment observed the ﬂow in one of three
arteries with arterial blood pressure and heart rate in the freely
moving rat.
sympathetic neurons, higher blood pressure produces blood
ﬂow increase. Namely, when tube (artery) size is constant
a n dh e a d( b l o o d )p r e s s u r ei sd i ﬀerent, higher head pressure
produces greater ﬂow (Figure 7). Therefore, to take the
inﬂuence of blood pressure changes into account, blood
ﬂow resistance or conductance is used to evaluate the net
eﬀect of the vascular bed. The studies have expressed blood
ﬂow resistance or vascular resistance that is blood pressure
divided by ﬂow. Changes in blood pressure always inﬂuence
blood ﬂow, but changes in blood ﬂow can make changes
in blood pressure when they inﬂuence the total peripheral
ﬂow resistance that is the net change in all the vascular beds.
When liquid in a tank ﬂows out from the exits, constricted
tubes together produce high back pressure, but dilated tubes
together produce low back pressure, and a combination of
constricted and dilated tubes results in no change in back
pressure (Figure 8). The ﬁnal example shows what happened
when the rat walked spontaneously. The ﬂow was shifted
from carotid artery to hindquarters (aortic terminal for legs)
without changes in blood pressure that was also supported
with an increase in cardiac output [2]. However, grooming
behavior increased blood pressure slightly (by 10mmHg)
with blood shift in the opposite direction [1]. Here, we see
changes in regional blood ﬂow resistance when amino acids
produce the pressor response.
Intracisternal injection of L-proline (1M) produced a
threefold increase in blood ﬂow resistance in the superior
mesenteric artery, double in renal artery, and no signiﬁcant
change in hindquarters [129]. With respect to each original
blood ﬂow with the pressor change (25%), superior mesen-
teric ﬂow was decreased but there was no signiﬁcant change
in either renal ﬂow or hindquarters ﬂow [129]. If the pressor
Tube
Higher head 
pressure
Greater ﬂow
Lower head 
pressure
Less ﬂow
“Blood pressure determines ﬂow rate”
Figure 7: Higher head pressure produces greater ﬂow when the
tube keeps the same diameter without any inﬂuence.
Low 
pressure
No change 
in pressure
High 
pressure
Height of liquid surface 
indicates the pressure
“Flow rate determines blood pressure”
Figure 8:Thepressureisincreasedinconstrictedtubesbutlowered
in dilated tubes and unchanged for a combination of constriction
and dilatation.
change is not considered, it appeared that vasoconstriction
only in the superior vascular bed contributed to the pressor
response. However, the resistance data indicate that L-
proline stimulation of the brain produced strong superior
mesentericandminorrenalvasoconstriction,resultinginthe
pressor response.
In the case of L-arginine (0.5M), vasoconstriction in
the superior mesenteric (80%) and renal arteries (60%)
was almost equivalent, but hindquarters resistance was
unchanged for 25% increase in blood pressure, suggesting an
equivalentcontributionofthesplanchnicvasoconstrictionto
the pressor response [127].
The original aim of D-arginine injected into the cisterna
magna was to examine the stereospeciﬁc eﬀect of L-arginine,
asmentionedabove.However,theresultsindicatedthatpres-
sor response to D-arginine was the same as L-arginine, but
distinctchangesinregionalbloodﬂowswereobserved.There
were almost equivalent increases in superior mesenteric
(60%) and renal resistances (45%) but a decrease in hind-
quarters resistance (35%) and an increase in total peripheral
blood ﬂow or cardiac output by calculation (23%), for theJournal of Amino Acids 7
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Figure 9: Simultaneous recordings of parameters of circulation of conscious rats in cisternal injection of GABA. HR, heart rate; BP, arterial
blood pressure; HQF, hindquarter blood ﬂow; SMF, superior mesenteric blood ﬂow; RF, renal blood ﬂow. Ten micromoles of GABA was
injected at 0 in the time scale. From Figure 1 of [43]. (Reprinted with permission from the Physiological Society of Japan).
pressor response (25%) to D-arginine (1M) [128]. The data
suggested the major contribution of cardiac output with the
minor one of total peripheral vascular resistance to the
pressor response of D-arginine, diﬀerently from L-arginine.
Each amino acid appeared to stimulate diﬀerent brain nuclei
relating to the cardiovascular regulation, resulting in the
common pressor response.
8. Regional Blood Flow Changes with Several
Amino Acids of the Depressor Action
Regionalbloodﬂowmeasurementinthreearteries(Figure 6)
was performed for GABA, L-β-alanine, and glycine, because
of the similarity of the molecular structure [43, 135]. Three
amino acids in common decreased hindquarters resistance
alone without signiﬁcant changes in superior mesenteric
resistance or renal resistance [135].
Figure 9 shows an example of blood ﬂow recordings in
three arteries with depressor and bradycardiac responses
to intracisternal injection of GABA [43]. The ﬂow changes
could be confusing, because hindquarters ﬂow showed no
change, but both superior and renal ﬂow decreased almost
in parallel to lowering blood pressure. It might be interesting
to see autoregulation of renal artery to keep ﬂow constant
to some extent during initiating lowering blood pressure,
compared with the exact parallel changes of superior mesen-
teric ﬂow and blood pressure (Figure 9). It is the case that,
when the vascular bed has no inﬂuence, ﬂow is decreased
depending on blood pressure lowering (Figure 7). GABA in
the brain could inhibit the tonic resistance in the hindquar-
tersvascularbedalonetoreducebloodpressure,alongwitha
bradycardia (probably cardiac output reduction). It appears
that hindquarters resistance is regulated by glycine receptors
and L-β-alanine-sensitive receptors in addition to GABA
receptors.
Further detailed evaluation of vascular resistance re-
sponses to intracisternal GABA stimulation suggested that
resting tone in the carotid in addition to hindquarters vas-
cular beds but not the superior mesenteric, celiac, and
renal vascular beds inﬂuenced by exogenously applied GABA
possiblythroughGABAreceptorsnotoccupiedwithendoge-
nousGABA[138,139].Thegroomingandwalkingbehaviors
produced blood shift between carotid artery and hindquar-
ters [1, 2]. Receptors for GABA and other depressor amino
acids may be involved in a program of neuronal networks for
producing the proper blood ﬂow shift during a behavior.8 Journal of Amino Acids
9. Peripheral Pathways Activated by Several
Amino Acidswith the Pressor Action
The pressor response to central amino acids could be
produced by increases in total peripheral resistance and/or
cardiac output. Vessels and heart are inﬂuenced by humoral
substances and neural activation via the brain (Figure 4).
When the pressor response is observed, we can diﬀerentiate
possible pathways pharmacologically. Autonomic ganglionic
blockade, receptor antagonists, and enzyme inhibitors have
been eﬀectively used for the pressor response to an intracis-
ternally injected amino acid.
Regional hemodynamic behaviors responding to venous
infusions of vasoactive agonists (vasopressin, angiotensin II,
noradrenaline, and adrenaline), which are possibly released
into the blood, are also useful to estimate central pathways
activated by an amino acid (Figure 4)[ 39]. Exogenously
infused vasopressin dose-dependently increased resistances
of all the vascular beds investigated except the celiac vascular
bed. Celiac resistance was unchanged while the other four
resistances were increased by increasing doses of vasopressin,
and it is abruptly increased only at the highest dose when
blood pressure increased by 50%. Angiotensin II and nora-
drenaline infusions produced in common various levels of
vasoconstrictioninfourarteriesotherthanthehindquarters.
Both vasoactive substances resulted in unchanged hindquar-
ters resistance, and the order of actions among the other four
arteries was distinctly diﬀerent. For 20% increase in blood
pressure, the most potent vasoconstriction was obtained in
renal and celiac arteries with noradrenaline infusion and in
renal artery with angiotensin II. Adrenaline infusion pro-
duced quite diﬀerent hemodynamic changes. As expected
from β-receptor stimulation for vasodilatation, hindquarter
resistance was decreased in a wide range of adrenaline
doses, but without increase in blood pressure in low doses.
Surprisingly, a celiac resistance increase compensated for the
loweredhindquartersresistance,maintainingbloodpressure.
Higher doses of adrenaline produced vasoconstriction of
other renal and carotid arteries, especially of superior
mesenteric artery.
With pharmacological data and regional vascular
responses to circulating vasoactive substances, the distinct
central pathways responding to each pressor amino acid
are estimated. Ganglionic blockade eﬀectively inhibited the
pressor response to L-arginine [127] and D-arginine [128],
suggesting that both amino acids could stimulate central
pathways relating to autonomic neurons. Vasodilatation in
hindquarters produced by D-arginine was attenuated by a
β-receptor inhibitor [128]. Taking hemodynamic data into
account, it is suggested that L-arginine would activate central
neurons relating to vascular sympathetic neurons in the
superior and renal vascular beds. Because adrenaline could
be released with the intracisternal injection, D-arginine
appears to stimulate nuclei relating to adrenal sympathetic
neurons.
With respect to L-cysteine [126], L-glutamate [126], and
L-proline [129], ganglionic blockade augmented the pressor
response. Additional intravenous injection of vasopressin
V1 receptor antagonist, however, completely abolished the
augmented pressor response to those amino acids. The data
suggest involvement of vasopressin release with amino acids.
Previous intravenous injection of vasopressin V1 receptor
antagonist alone, without ganglionic blockade, signiﬁcantly
attenuatedthepressorresponsetoL-prolineandL-glutamate
but not to L-cysteine. Namely, intracisternally injected
three amino acids are suggested to stimulate nuclei relating
to vasopressin containing neurons as well as autonomic
neurons.Pharmacologicaldatasuggestmajorinvolvementof
vasopressin release and minor roles of autonomic neurons
in the pressor response to applications of L-proline and
L-glutamate but major involvement of autonomic nervous
activation and minor role of vasopressin release in response
to L-cysteine.
Intracisternal injection of L-proline likely released
vasopressin but unchanged hindquarter resistance [129],
although exogenously infused vasopressin produced strong
vasoconstriction of hindquarters in a dose-dependent man-
ner [39]. One explanation is that the dilatation additionally
produced by adrenaline possibly released with L-proline
stimulation counters the vasoconstrictor action of vaso-
pressin, resulting in no change in resistance.
The ﬁndings indicate that each pressor amino acid listed
here activates diﬀerential central nuclei relating to peripheral
pathways of vascular sympathetic neurons, adrenal sympa-
thetic neurons, and vasopressin release via hypothalamus-
pituitary route. The amino acids other than D-arginine
are nonessential amino acids that can be endogenously
synthesized by enzymes for corresponding amino acids in
all cells. L-Glutamate is the excitatory neurotransmitter, L-
proline is a neurotransmitter candidate [140], L-cysteine
could be a neuromodulator [141], and L-arginine, a possible
precursor for nitric oxide, kyotorphin, and/or agmatine as
a b o v em e n t i o n e d ,i sn e u r o a c t i v e .
These non-essential amino acids can be detective in
all cells including neurons for protein synthesis. Therefore,
it is not easy to identify which neurons contain which
neurotransmitteraminoacids.Ofthem,L-glutamatecontent
in the brain tissue is known to be quite high, but it is
a multiplayer for metabolism too. A speciﬁc transporter,
vesicular glutamate transporter 2, for vesicular packing of
L-glutamate in the neuronal terminal has been used to be
a good marker of glutamatergic neurons to discriminate
the transmitter function of glutamate from metabolite pool
[142]. However, even vesicular glutamate transporter 2 coex-
ists with neurotransmitters other than L-glutamate in several
neurons [143], becoming a complex situation to clearly
delineate a ﬁxed marker of glutamatergic neurons. The
localization of neurons containing speciﬁc neurotransmitter
amino acids appears to need more eﬀorts to be identiﬁed.
10.Receptors atCentral Levelin
the PressorResponse
What receptors at central level are involved in the pressor
response to L-glutamate, L-proline, and L-arginine injected
into the cisterna magna of the freely moving rat? The pressor
response to L-proline was blocked by coinjection of a broadJournal of Amino Acids 9
spectrum antagonist of ionotropic amino acid receptors
kynurenic acid, but the response to L-glutamate and L-
arginine remained the same [144]. At least, the central recep-
torinvolvedinthepressorresponsetoL-prolineinjectedinto
thecisternamagnacouldbeionotropicexcitatoryaminoacid
receptors.
11. Possible Pathological Roles of
Amino Acids inthe Stroke
So far, I have mentioned the diﬀerential eﬀects of several
amino acids directly applied to the brain on the cardio-
vascular system. The amino acid concentrations in the
cerebrospinal ﬂuid will return to and remain low with the
help of the active role of the blood-brain barrier in the health
[11]. However, there are several reasons the blood-brain
barrier can be disrupted including clinical situations such as
cerebrovascular diseases of ischemic stroke and intracerebral
hemorrhage[145].Recentstudieshaverevealedthatthecon-
nection of the barrier can be broken by a molecular cascade
activated after ischemia, resulting in vasogenic edema and
cell death [145]. With respect to amino acids, pathological
amounts of L-glutamate are known to be released into
extracellular space in brain ischemia and probably involved
in toxic and lethal actions on neurons [146]. The acute
cerebrovascular diseases frequently present with mild to
moderate spontaneous elevations in blood pressure or acute
hypertension [147]. Unlike chronic hypertension as a cause
for the diseases, this accompanied hypertension is believed
to be a natural process to maintain the blood ﬂow for
survived regions. The chemical disturbance produced by
the ischemia might stimulate the nuclei responsible for
vascular sympathetic activation to result in acute hyper-
tension [148]. After opening of the blood-brain barrier,
some amino acids leaked into extracellular space may be
involved in additional chemical disturbance to stimulate
neurons responsible for blood pressure regulation. Amino
acids like L-cysteine derived after brain ischemia [149]m i gh t
be additional substances causing cell death in addition to
acute hypertension.
12. Conclusions
With respect to amino acids for which concentrations in
the cerebrospinal ﬂuid are lower than in the plasma, several
amino acids among exogenously applied ones showed car-
diovasculareﬀectsviacentralmechanisms,asmyexpectation
or hypothesis that amino acids might have some physiologi-
cal roles in the brain. The clue to initiate the current “amino
acids investigation” was the timely blood ﬂow shift in the rat
while grooming or walking, and the examinations resulted in
a list of additional neurotransmitter and/or neuromodulator
candidates relating to the central cardiovascular regulation
in freely moving rats. Several examined amino acids with
pressor or depressor action diﬀerentially inﬂuenced regional
blood ﬂow and central pathways. There is still much work
to be done to decipher how the brain controls blood ﬂow
shift for demanding organs. In order to develop hypotheses
for future studies, more regional blood ﬂow data together
with nervous activity might be useful at the in vivo level.
Determination of active sites in the brain responsible for
the cardiovascular response to stimulation with each amino
acid would be the most desirable for design of further
experiments.
The current paper mainly discussed eﬀects with pro-
teinogenic amino acids on cardiovascular regulation. Mam-
malian cells can produce plentiful nonproteinogenic amino
acids such as L-homocysteine by the related enzymes via
several metabolic pathways. A survey of such amino acids
for central cardiovascular regulation may provide additional
possibilities to ﬁnd new members for a list of mediators
between brain cells or other substances responsible for
producing chemical disturbance in brain diseases with
disruption of the blood-brain barrier.
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